Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
An. bras. dermatol ; 91(5,supl.1): 105-107, Sept.-Oct. 2016. tab, graf
Artigo em Inglês | LILACS | ID: biblio-837949

RESUMO

Abstract Cutaneous metastases from primary internal malignancies represent 0.7-9% of patients with cancer. We report a 65-year-old female patient referred for evaluation of normochromic papules on the trunk and upper limbs that had been present for three months. A skin biopsy revealed diffuse cutaneous infiltration by small round cell tumors. Immunohistochemistry was positive for AE1/AE3, CK7, estrogen receptor and mammaglobin. The final diagnosis was cutaneous metastasis of occult breast cancer, since the solid primary tumor was not identified. The location of the primary tumor can not be determined in 5-10% of cases. In these cases, 27% are identified before the patient’s death, 57% at autopsy, and the remaining 16% can not be located.


Assuntos
Humanos , Feminino , Idoso , Neoplasias Cutâneas/secundário , Neoplasias Primárias Desconhecidas/patologia , Neoplasias da Mama/patologia , Carcinoma/secundário , Pele/patologia , Neoplasias Cutâneas/patologia , Biópsia , Imuno-Histoquímica , Biomarcadores Tumorais/análise
2.
An Bras Dermatol ; 91(5 suppl 1): 105-107, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-28300911

RESUMO

Cutaneous metastases from primary internal malignancies represent 0.7-9% of patients with cancer. We report a 65-year-old female patient referred for evaluation of normochromic papules on the trunk and upper limbs that had been present for three months. A skin biopsy revealed diffuse cutaneous infiltration by small round cell tumors. Immunohistochemistry was positive for AE1/AE3, CK7, estrogen receptor and mammaglobin. The final diagnosis was cutaneous metastasis of occult breast cancer, since the solid primary tumor was not identified. The location of the primary tumor can not be determined in 5-10% of cases. In these cases, 27% are identified before the patient's death, 57% at autopsy, and the remaining 16% can not be located.


Assuntos
Neoplasias da Mama/patologia , Carcinoma/secundário , Neoplasias Primárias Desconhecidas/patologia , Neoplasias Cutâneas/secundário , Idoso , Biomarcadores Tumorais/análise , Biópsia , Feminino , Humanos , Imuno-Histoquímica , Pele/patologia , Neoplasias Cutâneas/patologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...